{
    "medicine_id": "43f7bfeef7d53cb7efa85034cdc1675d6df769ab",
    "platform_id": "DB05468",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v R411",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in asthma",
            "contraindications": {
                "disease": "Good safety profile observed in preclinical and clinical studies",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "R411 is a non steroid oral medicine for the treatment of asthma It is not immunosuppressive but blocks the activation and recruitment of cells involved in respiratory inflammation It is a dual acting competitive integrin antagonist as compared to previously developed single integrin antagonists or SIAs that prevents binding of V CAM1 to either a4b1 or a4b7",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}